By combining multi-omic analyses with in vitro characterization of KEAP1 loss in thyroid cancer, we demonstrate that these mutations are functionally relevant and capable of promoting tumorigenesis across diverse genetic landscapes. This evidence concerns the gene KEAP1 and thyroid gland carcinoma.